Introduction and objective:
Although routine treatment methods aim to aggressively destroy tumour tissues, they often fail to account for the correlations of tissue destruction and regeneration processes. Despite considerable progress in the field of oncology, it is worth noting the ancient ways of treatment using products from nature which potentially can effectively support current therapies.

Review methods:
The literature review used PubMed, Google Scholar, Scopus, Science Direct, Frontiers, Medline, Bookshelf, and Elsevier databases, taking into consideration publications from the last eight years. However, the subject of research is niche, forcing the use of older papers.

Brief description of the state of knowledge:
Plant extracts or their derivatives, tuberculin or sometimes mushrooms are most frequently employed in treating cancer. There are also publications on the anti-cancer properties of products from snail. Some researchers, however, believe there is little merit in turning to ancient methods. Extracts derived from snail bodies have been demonstrated to induce apoptosis in cancer cells, reduce their viability, and inhibit metastasis while exhibiting minimal or no detrimental impact on human cells. The interaction between snail hemolymph and anti-cancer drugs is sometimes synergistic. Snail organisms constitute specific micro-ecosystems that may contain micro-organisms. which, together with their metabolites, may also play an important role in immunotherapy. This problem, and the studies presented in the publications, must be verified by multiple methods.

Summary:
The products extracted from the snail have the potential to be of significant importance in the future treatment of cancer patients. While the findings presented in various studies are valuable, they are insufficient for the reliable verification of treatment methods, as they are made mainly under in vitro conditions.